ArticleVeterinary dermatology2026
Standardising Assessment of Superficial Pyoderma in Dogs: Proposal of a Severity Score.
Article in Veterinary dermatology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSuperficial pyoderma is common in dogs with atopic dermatitis, yet no validated and widely accepted severity scoring system exists. HYPOTHESIS/
objectivesTo develop a predictor for superficial pyoderma severity based on reliable objective lesion quantification combined with a clinician-assigned numerical severity rating. ANIMALS: Sixty client-owned dogs presenting with follicular papules, pustules, epidermal collarettes, and/or yellow crusts were prospectively enrolled. MATERIALS AND
methodsSix clinicians assessed lesion types, numerical and categorical disease severity, and treatment efficacy at baseline and at up to two follow-up visits. Lesions were quantified by counting individual papules and pustules, and by standardised area measurements for confluent papules/pustules, epidermal collarettes and crusts. Inter- and intra-clinician reliability were evaluated. A predictive model for pyoderma severity was subsequently developed using lesion quantification and clinician-assigned numerical severity scores.
resultsRecognition of specific lesion types and categorical severity assessments showed poor agreement between clinicians, indicating limited reliability for severity assessment. By contrast, combined lesion quantification demonstrated good inter- and intra-clinician reliability, and clinician-assigned numerical severity scores showed good inter-clinician reliability. The resulting predictive model demonstrated good agreement with clinician-assigned severity scores, estimating pyoderma severity on a continuous scale from 0 (no pyoderma) to 100 (worst conceivable pyoderma), with a mean absolute error of approximately nine severity points per case. CONCLUSIONS AND CLINICAL RELEVANCE: The proposed scoring system relies on combined lesion quantification without the need for subjective categorical grading. Although further validation is required, it provides a foundation for objective assessment of superficial pyoderma severity and introduces a mathematical model that translates combined lesion burden into clinician-perceived disease severity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.